"Dermatomyositis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
- Juvenile Myositis
- Juvenile Myositides
- Myositides, Juvenile
- Myositis, Juvenile
- Polymyositis Dermatomyositis
- Juvenile Dermatomyositis
- Dermatomyositides, Juvenile
- Dermatomyositis, Juvenile
- Juvenile Dermatomyositides
Dermatomyositis, Adult Type
- Dermatomyositis, Adult Type
- Adult Type Dermatomyositides
- Adult Type Dermatomyositis
- Dermatomyositides, Adult Type
Dermatomyositis, Childhood Type
- Dermatomyositis, Childhood Type
- Childhood Type Dermatomyositides
- Childhood Type Dermatomyositis
- Dermatomyositides, Childhood Type
Below are MeSH descriptors whose meaning is more general than "Dermatomyositis".
Below are MeSH descriptors whose meaning is more specific than "Dermatomyositis".
This graph shows the total number of publications written about "Dermatomyositis" by people in this website by year, and whether "Dermatomyositis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Dermatomyositis" by people in Profiles.
Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study. J Rheumatol. 2021 01 01; 48(1):114-122.
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195.
Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody. J Med Invest. 2018; 65(3.4):251-257.
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther. 2016 Feb; 36:46-52.
Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade. JAMA Dermatol. 2015 Feb; 151(2):195-9.
Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 2013 Mar; 143(3):814-824.
Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis. J Pediatr. 2011 Nov; 159(5):795-801.
The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis. J Cutan Pathol. 2010 Jun; 37(6):659-71.
Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol. 2009 Aug; 15(5):254-5.
Fulminant and accelerated presentation of dermatomyositis in two previously healthy young adult males: a potential role for endotheliotropic viral infection. J Cutan Pathol. 2009 Aug; 36(8):853-8.